您现在的位置是:【微信950216】亚星公司代理怎么联系 > 探索
Weight regain happens 4x faster after stopping GLP
【微信950216】亚星公司代理怎么联系2026-01-31 23:27:10【探索】9人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(934)
上一篇: 银行自查报告及整改措施
热门文章
站长推荐

金朝的“牵羊礼”是什么仪式?具体是怎样的?

中国现代名人故事:中国现代名人成龙

Trump's energy meeting shows he understands importance of energy dominance

二之国交错世界巫师幻兽哪个好 二之国交错世界巫师幻兽推荐

《爆水管》今日上映,艾伦首次演绎“反派感”角色,解锁反差人设

ทหารไทยคาดกัมพูชาเดินเข้าหาทำแฟร์สะดุด จนต้องยิงเตือน ก่อนประสานแก้ปัญหา

中国发现5.12亿年前花垣生物群 改写地球生物大灭绝事件历史

金朝的“牵羊礼”是什么仪式?具体是怎样的?
友情链接
- 《不正经的卡牌传说》PC版下载 Steam正版分流下载
- [新浪彩票]足彩第25181期任九:埃尔切坚韧不败
- 大乐透头奖4注970万无追加 奖池余额8.30亿元
- 增设分类垃圾桶 环保卫生引市民点赞
- 碧水源膜科技与京东京造签署战略合作协议 共筑国产化净水产业新生态
- 女孩得“怪病” 上课就发烧到家就好:确诊焦虑躯体化
- 夺帅手游兑换码长期有效一览
- ขบ.ขยายช่องทางบริการขอใบขับขี่
- Professor suggests Trump's strike in Nigeria was racially motivated violence
- Red state governor highlights Medicaid savings amid Minnesota fraud fallout
- 韩国首个商业运载火箭发射失败
- 精选足篮专家:楼云13连红 司马解球、永强8连红
- 快手回应大量色情内容刷屏:遭到灰黑产攻击,已报警
- 今天(3月21日)油价调整最新消息:或出现今年最大油价上涨
- 成都一高校学生失联,警方通报:全力搜寻
- 125 Adventure Quotes That Will Inspire Your Next Trip
- CR450动车组样车跑出453公里时速
- DMO Professional Development
- 双色球1罕见现象今年第3次开出 下期锁定这些特征 彩票
- 现货黄金再创历史新高 一度涨至2222.65美元/盎司